|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
EBOOKCENTRAL_ocn975223444 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
170311s2017 xx ob 001 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d OCLCQ
|d CUY
|d ZCU
|d MERUC
|d ICG
|d OCLCF
|d DKC
|d OCLCO
|d OCLCQ
|d OCLCO
|d SGP
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 974984389
|a 975034452
|a 975138263
|a 975427571
|a 1001859897
|a 1005964233
|
| 020 |
|
|
|a 9781119077619
|
| 020 |
|
|
|a 1119077613
|
| 020 |
|
|
|z 1119077605
|
| 020 |
|
|
|z 9781119077602
|
| 035 |
|
|
|a (OCoLC)975223444
|z (OCoLC)974984389
|z (OCoLC)975034452
|z (OCoLC)975138263
|z (OCoLC)975427571
|z (OCoLC)1001859897
|z (OCoLC)1005964233
|
| 050 |
|
4 |
|a RC862.I53
|b .A536 2017
|
| 060 |
1 |
0 |
|a WI 420
|
| 082 |
0 |
4 |
|a 616.344
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Podolsky, Daniel K.
|
| 245 |
1 |
0 |
|a Inflammatory Bowel Disease :
|b Diagnosis and Clinical Management.
|
| 260 |
|
|
|a Somerset :
|b John Wiley & Sons, Incorporated,
|c 2017.
|
| 300 |
|
|
|a 1 online resource (235 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Title Page ; Copyright Page; Contents; Preface; Section I Pathogenesis and Clinical Features; Chapter 1 Epidemiology and Pathogenesis; Clinical Take Home Messages; Epidemiology; Pathogenesis; Genetics; Microbiome; Environmental Triggers; Case Studies and Multiple Choice Questions; References; Answers to Questions; Chapter 2 Clinical Features and Diagnosis of Crohn's Disease; Clinical Take Home Messages; Clinical Features; Disease Course and Natural History; Diagnosis; History and Physical Examination; Laboratory Investigations; Serologic Markers; Endoscopy; Histology; Imaging Studies.
|
| 505 |
8 |
|
|a Case Studies and Multiple Choice QuestionsReferences; Answers to Questions; Chapter 3 Clinical Features and Diagnosis of Ulcerative Colitis; Clinical Take Home Messages; Clinical Features; Disease Course and Natural History; Diagnosis; History and Physical Examination; Laboratory Investigations; Serologic Markers; Endoscopy; Histology; Imaging Studies; Differential Diagnosis (UC and CD); Case Studies and Multiple Choice Questions; References; Answers to Questions; Chapter 4 Extraintestinal Manifestations of Inflammatory Bowel Diseases; Clinical Take Home Messages; Arthritis and Arthropathy.
|
| 505 |
8 |
|
|a Metabolic Bone DiseaseCutaneous Manifestations; Hepatobiliary Manifestations; Ophthalmologic Manifestations; Renal Complications; Thromboembolic and Cardiovascular Complications; Case Studies and Multiple Choice Questions; References; Answers to Questions; Section II Therapeutic Agents; Chapter 5 Aminosalicylates; Clinical Take Home Messages; Efficacy in Ulcerative Colitis; Efficacy in Crohn's Disease; Safety; Multiple Choice Questions; References; Answers to Questions; Chapter 6 Corticosteroids; Clinical Take Home Messages; Efficacy in Ulcerative Colitis; Efficacy in Crohn's Disease; Safety.
|
| 505 |
8 |
|
|a Case Studies and Multiple Choice QuestionsReferences; Answers to Questions; Chapter 7 Immunomodulators; Clinical Take Home Messages; Thiopurines; Efficacy in Ulcerative Colitis; Efficacy in Crohn's Disease; Safety; Methotrexate; Efficacy in Ulcerative Colitis; Efficacy in Crohn's Disease; Safety; Calcineurin Inhibitors; Efficacy in Ulcerative Colitis; Efficacy in Crohn's Disease; Case Studies and Multiple Choice Questions; References; Answers to Questions; Chapter 8 Biologic Therapies; Clinical Take Home Messages; Infliximab; Efficacy in Ulcerative Colitis; Efficacy in Crohn's Disease; Safety.
|
| 505 |
8 |
|
|a AdalimumabEfficacy in Ulcerative Colitis; Efficacy in Crohn's Disease; Certolizumab Pegol; Efficacy in Crohn's Disease; Golimumab; Natalizumab; Vedolizumab; Newer Therapies; Case Studies and Multiple Choice Questions; References; Answers to Questions; Chapter 9 Antibiotics; Clinical Take Home Messages; Efficacy in Ulcerative Colitis; Efficacy in Crohn's Disease; Other Microbial Modification Methods -- Probiotics and Fecal Microbiota Transplantation; Multiple Choice Questions; References; Answers to Questions; Section III Management; Chapter 10 Medical Management of Ulcerative Colitis.
|
| 500 |
|
|
|a Clinical Take Home Messages.
|
| 504 |
|
|
|a Includes bibliographical references at the end of each chapters and index.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Inflammatory bowel diseases.
|
| 650 |
|
2 |
|a Inflammatory Bowel Diseases
|
| 650 |
|
6 |
|a Affections intestinales inflammatoires.
|
| 650 |
|
7 |
|a Inflammatory bowel diseases
|2 fast
|
| 700 |
1 |
|
|a Ananthakrishnan, Ashwin.
|
| 700 |
1 |
|
|a Xavier, Ramnik J.
|
| 758 |
|
|
|i has work:
|a Inflammatory bowel disease (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCXKJ6Dgpk4xKpfJwvYHJwC
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Podolsky, Daniel K.
|t Inflammatory Bowel Disease : Diagnosis and Clinical Management.
|d Somerset : John Wiley & Sons, Incorporated, ©2017
|z 9781119077602
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4818683
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4818683
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 15315527
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 13543870
|
| 994 |
|
|
|a 92
|b IZTAP
|
